AstraZeneca and POZEN Inc. announced the U.S. Food and Drug Administration (FDA) approved VIMOVO delayed-release tablets for the relief of arthritis. The drug reduces the risk of getting gastric ulcers associated with taking some types of arthritis pain relief medicines.